Vivek Garipalli Clover Health Investments, Corp. (CLOV) insider trading activity

Vivek Garipalli is Director of CLOVER HEALTH INVESTMENTS, CORP. . Currently has a direct ownership of 1.86 Million shares of CLOV, which is worth approximately $5.61 Million. The most recent transaction as insider was on Aug 08, 2025, when has been sold 31,980 shares (Class A Common Stock) at a price of $2.17 per share, resulting in proceeds of $69,396. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.86M

31.72% 3M change

31.72% 12M change

Total Value Held $5.61 Million

Vivek Garipalli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2025	BUY Open market or private purchase	$69,396 $2.17 p/Share	31,980 Added 1.69%	1,856,247 Class A Common Stock
Aug 07 2025	BUY Open market or private purchase	$929,600 $2.24 p/Share	415,000 Added 18.53%	1,824,267 Class A Common Stock
Jan 07 2025	SELL Payment of exercise price or tax liability	$6,015,474 $3.6 p/Share	1,670,965 Reduced 54.25%	1,409,267 Class A Common Stock
Jan 07 2025	BUY Exercise of conversion of derivative security	-	1,670,965 Added 35.17%	3,080,232 Class A Common Stock
Aug 09 2024	BUY Open market or private purchase	$999,596 $1.88 p/Share	531,700 Added 27.39%	1,409,267 Class A Common Stock
Jun 17 2024	BUY Open market or private purchase	$1,000,426 $1.14 p/Share	877,567 Added 50.0%	877,567 Class A Common Stock
Jan 07 2024	SELL Payment of exercise price or tax liability	$1,483,011 $0.95 p/Share	1,561,065 Reduced 100.0%	0 Class A Common Stock
Jan 07 2024	BUY Exercise of conversion of derivative security	-	1,561,065 Added 50.0%	1,561,065 Class A Common Stock
Jan 07 2023	SELL Payment of exercise price or tax liability	$1,585,289 $1.01 p/Share	1,569,594 Reduced 100.0%	0 Class A Common Stock
Jan 07 2023	BUY Exercise of conversion of derivative security	-	1,569,594 Added 50.0%	1,569,594 Class A Common Stock
Jan 07 2022	SELL Payment of exercise price or tax liability	$5,260,847 $3.16 p/Share	1,664,825 Reduced 49.8%	1,677,873 Class B Common Stock
Jan 07 2022	BUY Exercise of conversion of derivative security	-	3,342,698 Added 50.0%	3,342,698 Class B Common Stock

Vivek Garipalli

Director

Franklin, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLOV shares.

Notify only if

Value

Insider Trading

Get notified when an Clover Health Investments, Corp. insider buys or sells CLOV shares.

Notify only if

Operation

Value

Type

News

Receive news related to CLOVER HEALTH INVESTMENTS, CORP.

Track Activities on CLOV

Account